Oric Pharmaceuticals (ORIC) Shares Outstanding (2019 - 2026)

Oric Pharmaceuticals (ORIC) has 8 years of Shares Outstanding (Entity) data on file, last reported at $103.5 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 45.59% year-over-year to $103.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $103.5 million (up 45.59% YoY) and the FY2025 annual result came in at $98.5 million, up 38.73% from the prior year.
• Shares Outstanding (Entity) climbed to $103.5 million in Q1 2026, from $98.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $103.5 million in Q1 2026 to a low of $39.4 million in Q1 2022.
• A 5-year average of $65.1 million and a median of $67.4 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) rose 0.62% — and 2024, when it surged 49.52%.
• Tracing ORIC's Shares Outstanding (Entity) over 5 years: stood at $45.1 million in 2022, then grew by 21.68% to $54.9 million in 2023, then gained by 29.45% to $71.0 million in 2024, then jumped by 38.73% to $98.5 million in 2025, then increased by 5.03% to $103.5 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $103.5 million (Q1 2026), $98.5 million (Q4 2025), and $97.3 million (Q3 2025), per Business Quant data.